fda decision on tirzepatide reconsidering its to take off its drug shortage list Tirzepatide gains FDA approval for

In clinical trials supported by Novo Nordisk, gallstones were reported in 1.5 percent of participants taking a 0.5 mg dose of semaglutide and 0.4 percent of those taking the 1 mg dose

Taking gabapentin and methocarbamol too close together can amplify their sedative effects

Brain atrophy may prevent an increase in intracranial pressure (ICP) and cerebral herniation in patients with large cerebral infarctions, by providing additional intracranial space for compensation 9,10,11,12

Back UCL (5 Feb 2025) 'GLP-1 drug shows little benefit for people with Parkinson's disease'

Dilution only changes the concentration (the amount of peptide per mL of liquid), not the overall potency of the compound in the vial